Who is sponsoring NCT04000867?

NCT04000867 is sponsored by ZyGood LLC.

What drugs are being tested in NCT04000867?

Interventions in NCT04000867: Transcutaneous Magnetic Stimulation (TCMS).

What condition does NCT04000867 study?

NCT04000867 studies Diabetic Peripheral Neuropathy.

Is NCT04000867 still recruiting?

NCT04000867 is currently status unknown. Last updated 27 June 2019.

Last reviewed 2019-06-27 · How we verify

NCT04000867

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment for Foot Pain Caused by Diabetic Neuropathy Using Recurrent TransCutaneous Magnetic Stimulation (TCMS)

Status unknown NA Last updated 27 June 2019

What this trial tests

NA trial testing Transcutaneous Magnetic Stimulation (TCMS) in Diabetic Peripheral Neuropathy in 20 participants. Status unknown.

Timeline

1 August 2019

Primary endpoint
1 December 2019

1 February 2020

Quick facts

Lead sponsor	ZyGood LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	20
Start date	1 August 2019
Primary completion	1 December 2019
Estimated completion	1 February 2020

Drugs / interventions tested

Transcutaneous Magnetic Stimulation (TCMS)

Conditions studied

Diabetic Peripheral Neuropathy — all drugs for Diabetic Peripheral Neuropathy →

Sponsor

ZyGood LLC

Who can join

18 and older, any sex, with Diabetic Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will evaluate whether an experimental medical device that emits a series of brief, intense magnetic pulse will relieve foot pain from Diabetic Neuropathy (DN) if used weekly for a month

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Peripheral Neuropathy

Currently open trials in the same condition.

NCT07380880 — Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neurop · NA · recruiting
NCT06591780 — Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy · NA · recruiting
NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
NCT07085130 — The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy · NA · active not recruiting
NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04000867 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ZyGood LLC
Last refreshed: 27 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04000867.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing